Auro Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve Audited Financial Results ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Auro Laboratories Ltd has informed BSE that a meeting of the Board of Directors is scheduled for May 29, 2026. The meeting will consider and approve the Audited Financial Results for the quarter and year ended March 31, 2026, along with the Auditors' Report. The company has also closed its trading window from April 01, 2026, which will re-open 48 hours after the financial results are announced to the stock exchange. This is a standard regulatory intimation under SEBI Listing Regulations and does not contain any financial data or results at this stage.
This is a routine filing announcing an upcoming board meeting to approve Q4/FY2026 results. No specific impact on stock price can be determined until actual financial results are disclosed. The trading window closure is standard practice to prevent insider trading ahead of material announcements.